Edition:
United Kingdom

Bio Path Holdings Inc (BPTH.OQ)

BPTH.OQ on NASDAQ Stock Exchange Capital Market

0.61USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$0.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,529
52-wk High
$5.85
52-wk Low
$0.58

Chart for

About

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize,... (more)
No analyst recommendations are available for .

Overall

Beta: 3.13
Market Cap(Mil.): $38.52
Shares Outstanding(Mil.): 100.06
Dividend: --
Yield (%): --

Financials

  BPTH.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.07 -- --
ROI: -70.12 1.79 14.61
ROE: -83.80 3.28 16.33

BRIEF-Bio-Path Holdings Reports Full Year 2017 Financial Results

* PATH HOLDINGS REPORTS FULL YEAR 2017 FINANCIAL RESULTS Source text for Eikon: Further company coverage:

03 Apr 2018

Earnings vs. Estimates